Alkermes Investigational Site

Seattle, Washington 98133

0 studies enrolling now · 4 studies all time

What they study most

Major Depressive Disorder, Multiple Sclerosis, Relapsing Remitting Multiple Sclerosis

Studies at this site

• A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1 — Completed
• A Tolerability Study of ALKS 8700 in Subjects With Relapsing Remitting Multiple Sclerosis (RRMS) EVOLVE-MS-2 — Completed
• A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - FORWARD-5 Study — Completed
• A Long-Term Safety Study of ALKS 5461 — Completed